Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parallel detection and quantification using nine immunoassays in a protein microarray for drug from serum samples.

Hongwu Du1, Weiping Yang, Wanli Xing

  • 1Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, People's Republic of China.

Biomedical Microdevices
|June 9, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering Mesenchymal Stem Cell Spheroids and Brain Organoids: Advanced 3D Culture Platforms for Neurodegenerative Disease Cell Therapy.

Stem cell reviews and reports·2026
Same author

Nebulized delivery of multi-modular stem cell-derived exosomes for the treatment of pulmonary fibrosis.

Nanomedicine : nanotechnology, biology, and medicine·2026
Same author

Multifunctional DNA nanoflower recruits neural stem cells via ROS-responsive extracellular drug release to promote neurogenesis.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Application of umbilical cord mesenchymal stem cell lysate in dry eye syndrome and retinal injury.

International ophthalmology·2026
Same author

CRISPR in Alzheimer's Disease: Engineering Genetic Solutions for Neurodegenerative Resilience.

Current neuropharmacology·2026
Same author

ROS-Responsive Hybrid Nanoparticles Enable Dual-Target Neurovascular Repair via Blood-Brain Barrier-on-Chip Validation.

Small (Weinheim an der Bergstrasse, Germany)·2026

A novel protein microarray system accurately detects and quantifies nine prohibited drugs in serum. This method offers a reliable alternative to ELISA for large-scale drug screening.

Area of Science:

  • Biochemistry
  • Analytical Chemistry
  • Immunotechnology

Background:

  • Developing sensitive and specific methods for detecting prohibited drugs in biological samples is crucial for clinical diagnostics and forensic analysis.
  • Existing methods like ELISA can be time-consuming and may not be suitable for high-throughput screening.
  • Protein microarrays offer a potential platform for multiplexed and rapid analysis of various analytes.

Purpose of the Study:

  • To develop and validate a protein microarray system for the simultaneous detection and quantification of nine prohibited drugs in human serum.
  • To assess the performance of the developed microarray system by comparing it with established methods like ELISA.
  • To evaluate the suitability of the protein microarray for large-scale screening applications.

Main Methods:

Related Experiment Videos

  • Utilized chemically modified slides as substrates for printing drug-bovine serum albumin (BSA) conjugates.
  • Immobilized haptens on the microarray surface, ensuring preservation of their biological function for antibody binding.
  • Employed mouse IgG as an internal control for quantitative data processing and analysis.

Main Results:

  • The developed protein microarray successfully preserved the biological function of immobilized haptens, enabling specific antibody binding.
  • Quantitative analysis was feasible using mouse IgG as an internal control.
  • Qualitative results obtained from the protein microarray showed no significant difference compared to those from ELISA.
  • The system demonstrated capability for simultaneous detection of multiple analytes.

Conclusions:

  • The developed protein microarray system provides a sensitive and specific method for detecting and quantifying prohibited drugs in serum.
  • This technology offers comparable accuracy to ELISA but with the advantage of multiplexing and potential for high-throughput screening.
  • The protein microarray platform is well-suited for large-scale screening of various analytes in serum, offering a valuable tool for diagnostics and research.